These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36240831)

  • 1. Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020.
    Murhekar MV; Gupta N; Hasan AZ; Kumar MS; Kumar VS; Prosperi C; Sapkal GN; Thangaraj JWV; Kaduskar O; Bhatt V; Deshpande GR; Thankappan UP; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma S; Sarmah NP; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Shrivastava AK; Chonker SK; Tilekar B; Tandale BV; Ahmad M; Sangal L; Winter A; Mehendale SM; Moss WJ; Hayford K
    Lancet Glob Health; 2022 Nov; 10(11):e1655-e1664. PubMed ID: 36240831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020.
    Thangaraj JWV; Prosperi C; Kumar MS; Hasan AZ; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sarmah NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murherkar MV
    PLoS One; 2024; 19(3):e0297385. PubMed ID: 38551928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
    Prosperi C; Thangaraj JWV; Hasan AZ; Kumar MS; Truelove S; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Cutts FT; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murhekar MV
    Vaccine; 2023 Jan; 41(2):486-495. PubMed ID: 36481106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K
    PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
    Hayford K; Mutembo S; Carcelen A; Matakala HK; Munachoonga P; Winter A; Wanyiri JW; Searle K; Mwansa FD; Mwiche A; Phiri C; Book C; Thuma PE; Moss WJ
    Vaccine; 2019 Apr; 37(17):2387-2393. PubMed ID: 30905529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles and rubella IgG seroprevalence in persons 6 month-35 years of age, Mongolia, 2016.
    Nogareda F; Gunregjav N; Sarankhuu A; Munkhbat E; Ichinnorov E; Nymadawa P; Wannemuehler K; Mulders MN; Hagan J; Patel MK
    Vaccine; 2020 May; 38(26):4200-4208. PubMed ID: 32381479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences of sharing results of community based serosurvey with participants in a district of Maharashtra, India.
    Salvi N; Itta KC; Lachyan A; Hasan AZ; Prosperi C; Kumar MS; Wesley Vivian Thangaraj J; Kaduskar O; Bhatt V; Sapkal GN; Murhekar M; Gupta N; Mehendale S; Hayford K; Moss WJ; Chauhan S; Kulkarni R
    PLoS One; 2022; 17(8):e0271920. PubMed ID: 35925959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies.
    Mak J; Patenaude BN; Mutembo S; Pilewskie ME; Winter AK; Moss WJ; Carcelen AC
    Am J Trop Med Hyg; 2024 Jul; 111(1):121-128. PubMed ID: 38772386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling.
    Hachiya M; Vynnycky E; Mori Y; Do HT; Huynh MK; Trinh LH; Nguyen DD; Tran NAT; Hoang TT; Hoang HHT; Vo NDT; Le TH; Ichimura Y; Miyano S; Okawa S; Thandar MM; Yokobori Y; Inoue Y; Mizoue T; Takeda M; Komada K
    Int J Infect Dis; 2024 Jul; 144():107053. PubMed ID: 38641317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
    Carcelen AC; Mutembo S; Matakala KH; Chilumba I; Mulundu G; Monze M; Mwansa FD; Moss WJ; Hayford K
    Am J Trop Med Hyg; 2021 May; 104(6):2229-2232. PubMed ID: 33939639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles immunity gaps among children and adolescents with HIV in Zambia despite high measles vaccination and antiretroviral therapy coverage.
    Mutembo S; Yang Y; Carcelen A; Winter AK; Mwansa FD; Chilumba I; Mutale I; Chongwe G; Monze M; Mulundu G; Nkamba H; Mulenga L; Hayford K; Moss WJ
    AIDS; 2023 Nov; 37(13):2021-2029. PubMed ID: 37418463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of Dried Blood Spots Collected on HemaSpot HF Devices Compared to Venous Blood Specimens To Estimate Measles and Rubella Seroprevalence.
    Prosperi C; Kaduskar O; Bhatt V; Hasan AZ; Vivian Thangaraj JW; Kumar MS; Sabarinathan R; Kumar S; Duraiswamy A; Deshpande GR; Padinjaremattathil Thankappan U; Chauhan SL; Kulkarni RN; Bansal AK; Chaaithanya IK; Salvi NR; Sharma S; Moss WJ; Sangal L; Gupta N; Murherkar MV; Mehendale SM; Sapkal GN; Hayford K
    mSphere; 2021 Aug; 6(4):e0133020. PubMed ID: 34259557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
    Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E
    PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
    Tohme RA; François J; Wannemuehler K; Magloire R; Danovaro-Holliday MC; Flannery B; Cavallaro KF; Fitter DL; Purcell N; Dismer A; Tappero JW; Vertefeuille JF; Hyde TB
    Trop Med Int Health; 2014 Sep; 19(9):1105-15. PubMed ID: 25041586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L; Germann D; Bally F; Schopfer K
    Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles and rubella immunity in the population of Bhutan, 2017.
    Wangchuk S; Nogareda F; Tshering N; Khandu L; Pelden S; Wannemuehler K; Wangdi S; Wangchuk U; Mulders M; Tamang T; Patel MK
    Vaccine; 2019 Oct; 37(43):6463-6469. PubMed ID: 31500970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022.
    Shanmugasundaram D; Viswanathan R; Winter AK; Agarwal A; Roychowdhury B; Muliyil D; Prasad GRV; Pushpalatha K; Gowda M; Singh P; Priyasree J; Bonu R; Jha S; Kumar Jena S; Jain S; Suri V; Hebbale V; Jain A; Mary Abraham A; Mishra B; Kumar Pati B; Biswas D; Pratkeye D; Ashok M; Singh MP; Dhodapkar R; Ray R; Gadepalli R; Ratho RK; Rani S; Shukla S; Ali A S; Lakshmi Nag V; Sabarinathan R; Saravana Kumar V; Priya R P; Dwibedi B; Sapkal G; Singh H; Singh K; Tiwari L; Jain M; Mondal N; Sreenivasan P; Mahantesh S; Verma S; Awasthi S; Malik S; Santhanam S; Datta S; Kumar A; Kant Chowdhary B; Khera D; Jain M; Kumar P; Pati S; Tripathi S; Murhekar M
    Vaccine; 2024 Oct; 42(24):126077. PubMed ID: 38960788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
    Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
    Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella seroprevalence using residual samples from the South African measles surveillance program: a cross-sectional analytic study.
    Motaze NV; Makhathini L; Smit SB; Adu-Gyamfi CG; Fortuin M; Wiysonge CS; Suchard SM
    Hum Vaccin Immunother; 2020 Nov; 16(11):2656-2662. PubMed ID: 32298204
    [No Abstract]   [Full Text] [Related]  

  • 20. Who gets vaccinated in a measles-rubella campaign in Nepal?: results from a post-campaign coverage survey.
    Danovaro-Holliday MC; Rhoda DA; Lacoul M; Prier ML; Gautam JS; Pokhrel TN; Dixit SM; Rajbhandari RM; Bose AS
    BMC Public Health; 2022 Feb; 22(1):221. PubMed ID: 35114969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.